Exhibit 16.1
June 5, 2020
US Securities and Exchange Commission
Office of the Chief Accountant
100 F Street, NE
Washington, DC 20549
Re: Benitec Biopharma Inc
FileNo. 001-39267
Dear Sir or Madam:
We have read Item 4.01 of Form8-K of Benitec Biopharma Inc. dated June 5, 2020 and are in agreement with the statements contained solely as it relates to our Firm.
Very truly yours,
| /s/ GRANT THORNTON AUDIT PTY LTD |
| Sydney, NSW Australia |
| June 5, 2020 |
